Aptevo Therapeutics Inc (APVO):企業の財務・戦略的SWOT分析

◆英語タイトル:Aptevo Therapeutics Inc (APVO) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1645
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥16,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥32,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Aptevo Therapeutics Inc (APVO) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Aptevo Therapeutics Inc (Aptevo) is a biotechnology company that develops and commercializes oncology and hematology therapeutics. Its pipeline products include APVO436 for the treatment of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML); ALG.APV-527 for potential treatment of a broad spectrum of cancers including mesothelioma, cervical, prostate, renal, breast, non-small-cell-lung, gastric, colorectal and bladder cancers; APVO603 for solid tumors. The company has received Orphan Drug Designation (ODD) for its pipeline product APVO436 from the US FDA for the treatment of acute myelogenous leukemia (AML). The pipeline immuno-oncology candidates are built on its proprietary Adaptir platform technology. Aptevo is headquartered in Seattle, Washington, the US.

Aptevo Therapeutics Inc Key Recent Developments

Nov 06,2019 Aptevo Therapeutics reports third quarter 2019 financial results
Oct 03,2019 Aptevo Therapeutics provides corporate and pipeline update
Aug 09,2019 Aptevo Therapeutics reports second quarter 2019 financial results
Aug 07,2019 Aptevo Therapeutics receives $4.3 million milestone payment from Saol International

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Aptevo Therapeutics Inc – Key Facts
Aptevo Therapeutics Inc – Key Employees
Aptevo Therapeutics Inc – Key Employee Biographies
Aptevo Therapeutics Inc – Major Products and Services
Aptevo Therapeutics Inc – History
Aptevo Therapeutics Inc – Company Statement
Aptevo Therapeutics Inc – Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Company Overview
Aptevo Therapeutics Inc – Business Description
Aptevo Therapeutics Inc – Corporate Strategy
Aptevo Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Aptevo Therapeutics Inc – Strengths
Aptevo Therapeutics Inc – Weaknesses
Aptevo Therapeutics Inc – Opportunities
Aptevo Therapeutics Inc – Threats
Aptevo Therapeutics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Aptevo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Aptevo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Aptevo Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 06, 2019: Aptevo Therapeutics reports third quarter 2019 financial results
Oct 03, 2019: Aptevo Therapeutics provides corporate and pipeline update
Aug 09, 2019: Aptevo Therapeutics reports second quarter 2019 financial results
Aug 07, 2019: Aptevo Therapeutics receives $4.3 million milestone payment from Saol International
May 09, 2019: Aptevo Therapeutics reports first quarter 2019 financial results
Apr 15, 2019: Aptevo Therapeutics reports IXINITY and pipeline progress
Mar 18, 2019: Aptevo therapeutics reports 2018 financial results and provides business update
Jan 07, 2019: Aptevo Therapeutics highlights key 2019 priorities
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Aptevo Therapeutics Inc, Key Facts
Aptevo Therapeutics Inc, Key Employees
Aptevo Therapeutics Inc, Key Employee Biographies
Aptevo Therapeutics Inc, Major Products and Services
Aptevo Therapeutics Inc, History
Aptevo Therapeutics Inc, Key Competitors
Aptevo Therapeutics Inc, Ratios based on current share price
Aptevo Therapeutics Inc, Annual Ratios
Aptevo Therapeutics Inc, Annual Ratios (Cont...1)
Aptevo Therapeutics Inc, Interim Ratios
Aptevo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Aptevo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Aptevo Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Aptevo Therapeutics Inc, Performance Chart (2015 - 2019)
Aptevo Therapeutics Inc, Ratio Charts
Aptevo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Aptevo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Aptevo Therapeutics Inc (APVO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • EBTEC Corporation:企業の戦略・SWOT・財務分析
    EBTEC Corporation - Strategy, SWOT and Corporate Finance Report Summary EBTEC Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Great Southern Bancorp Inc:企業の戦略・SWOT・財務分析
    Great Southern Bancorp Inc - Strategy, SWOT and Corporate Finance Report Summary Great Southern Bancorp Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Pharmaceutical Product Development LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Pharmaceutical Product Development LLC (PPD) is a contract research organization (CRO), which offers drug discovery, development and lifecycle management services. The company’s service portfolio encompasses early development clinical trial services, drug research and development, regulatory …
  • Consolidated Edison Inc (ED):企業の財務・戦略的SWOT分析
    Consolidated Edison Inc (ED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Saline Water Conversion Corp:発電所・企業SWOT分析
    Saline Water Conversion Corp - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Global Petroleum Ltd (GBP):石油・ガス:M&Aディール及び事業提携情報
    Summary Global Petroleum Ltd (Global Petroleum) is an oil and gas company that offers oil and gas exploration and development services. The company operates through a portfolio of oil and gas projects in offshore Namibia and others. Its Namibian Project is into petroleum and gas exploration and Juan …
  • Hollingsworth & Vose Company:企業の戦略的SWOT分析
    Hollingsworth & Vose Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • The New Zealand Refining Co Ltd (NZR):企業の財務・戦略的SWOT分析
    The New Zealand Refining Co Ltd (NZR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Amadeus IT Group S.A.:企業の戦略・SWOT・財務情報
    Amadeus IT Group S.A. - Strategy, SWOT and Corporate Finance Report Summary Amadeus IT Group S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • CytomX Therapeutics Inc (CTMX):企業の財務・戦略的SWOT分析
    Summary CytomX Therapeutics Inc (CytomX) is a clinical-stage biopharmaceutical company which develops novel therapeutic antibodies and Probody therapeutics for the treatment of cancer. The company’s leading product candidates include CX-072, CX-2009, BMS-986249, CX-2029, CX-188, probody drug conjuga …
  • Raisio plc:企業の戦略・SWOT・財務情報
    Raisio plc - Strategy, SWOT and Corporate Finance Report Summary Raisio plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Alembic Pharmaceuticals Ltd (APLLTD):製薬・医療:M&Aディール及び事業提携情報
    Summary Alembic Pharmaceuticals Ltd (APL) is a pharmaceutical company which manufactures and markets generic pharmaceutical products. The company’s active pharmaceutical ingredients include macrolides, NSAIDs, and other drugs. It also offers branded formulations in the areas of antibiotics and antib …
  • The British United Provident Association Ltd-製薬・医療分野:企業M&A・提携分析
    Summary The British United Provident Association Ltd (Bupa) is a leading global healthcare group. It offers health insurance and other funding products, chronic disease management services, home healthcare services, workplace health services and care services, comprising residential and nursing home …
  • Galaxy Entertainment Group Ltd:企業の戦略・SWOT・財務分析
    Galaxy Entertainment Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Galaxy Entertainment Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • TECSYS Inc. (TCS):企業の財務・戦略的SWOT分析
    TECSYS Inc. (TCS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Dot Foods, Inc.:企業の戦略・SWOT・財務情報
    Dot Foods, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dot Foods, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Enterprise Products Partners LP (EPD)-石油・ガス分野:企業M&A・提携分析
    Summary Enterprise Products Partners L.P. (Enterprise Products) is a provider of midstream energy services. The company‘s integrated midstream operations include natural gas gathering, treating, processing, transportation and storage; natural gas liquid transportation, fractionation, storage, and im …
  • Ansaldo Energia SpA:電力:M&Aディール及び事業提携情報
    Summary Ansaldo Energia SpA (Ansaldo Energia), a subsidiary of CDP Equity SpA, is a power generation company and a supplier of power plant equipment and related services. It provides power plant equipment such as gas turbines, steam turbines, turbo generators, and hydro-generators used in fossil fue …
  • Old Dominion Electric Cooperative:企業の戦略的SWOT分析
    Old Dominion Electric Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Skinvisible Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Skinvisible Pharmaceuticals Inc (Skinvisible Pharmaceuticals), a subsidiary of Skinvisible Inc, is a pharmaceutical company that develops and manufactures prescription and over the counter dermatology, medical, cosmetic, consumer goods, and skincare products. The company provides products su …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆